Cases & Deals

King Pharmaceuticals launches patent infringement action regarding Avinza®

Clients King Pharmaceuticals, Inc.

Jones Day represents King Pharmaceuticals, Inc. in a Paragraph IV patent infringement litigation involving generic Morphine Sulfate Extended-Release Capsules USP for 30, 60, 90 and 120 mg doses.

King Pharmaceuticals Inc. et al v. Actavis, Inc. et al (2-09-cv-06585) NJD

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.